These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20425270)

  • 21. [Role of secreted and lipoprotein-associated phospholipase A2 in cardiovascular risk].
    Ferri N; Corsini A
    G Ital Cardiol (Rome); 2014 Dec; 15(12):664-9. PubMed ID: 25533115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Darapladib.
    Bui QT; Wilensky RL
    Expert Opin Investig Drugs; 2010 Jan; 19(1):161-8. PubMed ID: 20001561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC; Tselepis AD
    Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment.
    Iwase M; Sonoki K; Sasaki N; Ohdo S; Higuchi S; Hattori H; Iida M
    Atherosclerosis; 2008 Feb; 196(2):931-6. PubMed ID: 17350631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.
    Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH
    Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein-associated phospholipase A2 as a target of therapy.
    Macphee CH; Nelson JJ; Zalewski A
    Curr Opin Lipidol; 2005 Aug; 16(4):442-6. PubMed ID: 15990594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.
    Gong HP; Du YM; Zhong LN; Dong ZQ; Wang X; Mao YJ; Lu QH
    Lipids Health Dis; 2011 Jan; 10():13. PubMed ID: 21247435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.
    Zalewski A; Macphee C
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):923-31. PubMed ID: 15731492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂.
    Rizos CV; Liberopoulos EN; Tellis CC; Florentin M; Elisaf MS; Tselepis AD
    Metab Syndr Relat Disord; 2011 Jun; 9(3):217-23. PubMed ID: 21352079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.
    Mannheim D; Herrmann J; Versari D; Gössl M; Meyer FB; McConnell JP; Lerman LO; Lerman A
    Stroke; 2008 May; 39(5):1448-55. PubMed ID: 18356547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of lipoprotein-associated phospholipase A2 (Lp-PLA₂) in cardiovascular disease.
    Ikonomidis I; Michalakeas CA; Lekakis J; Parissis J; Anastasiou-Nana M
    Rev Recent Clin Trials; 2011 May; 6(2):108-13. PubMed ID: 21241231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of atherosclerosis in apolipoprotein E-deficient mice by lentivirus-mediated gene silencing of lipoprotein-associated phospholipase A2.
    Zhang H; Zhang J; Shen D; Zhang L; He F; Dang Y; Li L
    Biochem Biophys Res Commun; 2012 Oct; 427(3):557-62. PubMed ID: 23022183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemia.
    Tselepis AD; Hahalis G; Tellis CC; Papavasiliou EC; Mylona PT; Kourakli A; Alexopoulos DC
    J Lipid Res; 2010 Nov; 51(11):3331-41. PubMed ID: 20625038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
    Epps KC; Wilensky RL
    J Intern Med; 2011 Jan; 269(1):94-106. PubMed ID: 21054587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study.
    Kim JY; Hyun YJ; Jang Y; Lee BK; Chae JS; Kim SE; Yeo HY; Jeong TS; Jeon DW; Lee JH
    Am J Clin Nutr; 2008 Sep; 88(3):630-7. PubMed ID: 18779277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome.
    Chung H; Kwon HM; Kim JY; Yoon YW; Rhee J; Choi EY; Min PK; Hong BK; Rim SJ; Yoon JH; Lee SJ; Park JK; Kim MH; Jo M; Yang JH; Lee BK
    Yonsei Med J; 2014 Nov; 55(6):1507-15. PubMed ID: 25323886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
    Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
    Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.